Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) EBT Margin (2016 - 2025)

Historic EBT Margin for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 14.32%.

  • Veracyte's EBT Margin fell 2200.0% to 14.32% in Q3 2025 from the same period last year, while for Sep 2025 it was 6.26%, marking a year-over-year increase of 81800.0%. This contributed to the annual value of 5.78% for FY2024, which is 269900.0% up from last year.
  • Veracyte's EBT Margin amounted to 14.32% in Q3 2025, which was down 2200.0% from 0.96% recorded in Q2 2025.
  • Veracyte's 5-year EBT Margin high stood at 14.54% for Q3 2024, and its period low was 124.41% during Q1 2021.
  • In the last 5 years, Veracyte's EBT Margin had a median value of 9.82% in 2023 and averaged 14.4%.
  • As far as peak fluctuations go, Veracyte's EBT Margin plummeted by -867700bps in 2021, and later skyrocketed by 1030700bps in 2022.
  • Veracyte's EBT Margin (Quarter) stood at 16.81% in 2021, then soared by 75bps to 4.29% in 2022, then crashed by -624bps to 31.03% in 2023, then surged by 109bps to 2.9% in 2024, then skyrocketed by 394bps to 14.32% in 2025.
  • Its last three reported values are 14.32% in Q3 2025, 0.96% for Q2 2025, and 6.49% during Q1 2025.